another new "glitazone" for type 2 diabetes, Actos (pioglitazone)
August 1999
You'll soon see another new "glitazone" for type 2 diabetes, Actos (pioglitazone).
This is the third one...after Rezulin (troglitazone) and Avandia (rosiglitazone).
These drugs lower blood glucose by improving insulin sensitivity.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote